Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: Interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference40 articles.
1. Schizophrenia and other psychotic disorders,2000
2. Review: Lifetime prevalence of schizophrenia and related disorders is about 5.5 per 1000, but there is significant variation between regions;Johannessen;Evid Based Ment Health.,2003
3. Improving patient outcomes in schizophrenia: Achieving remission;Nasrallah;J Psychopharmacol.,2006
4. Towards consensus in the long-term management of relapse prevention in schizophrenia;Taylor;Hum Psychopharmacol.,2005
5. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study [published correction appears in Schizophr Res. 2007;96:273–274];Davidson;Schizophr Res.,2007
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Developing and testing unconditional cash transfer strategies among young adults with first-episode psychosis in South Africa: a study protocol for a pilot randomised control trial (PRS-FEP trial);BMJ Open;2022-12
2. Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis;Schizophrenia Bulletin;2022-08-04
3. The effect of dialectical behaviour therapy in autism spectrum patients with suicidality and/ or self-destructive behaviour (DIASS): study protocol for a multicentre randomised controlled trial;BMC Psychiatry;2020-03-17
4. Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation;Psychiatry Research;2019-04
5. Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics;Neuropsychiatric Disease and Treatment;2018-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3